Management of anaphylaxis

Reading File
Finding Sources
Searching PubMed

"anaphylaxis" AND "management"

Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive, detailed information from multiple major textbooks. Let me compile a thorough, well-structured response.

Management of Anaphylaxis

Anaphylaxis is a severe, life-threatening systemic hypersensitivity reaction driven by mast cell and basophil degranulation, releasing histamine, tryptase, prostaglandin D2, and leukotriene C4. The principal target organs are cardiovascular, cutaneous, respiratory, and gastrointestinal. Rapid recognition and immediate epinephrine administration are the cornerstones of management.

Diagnosis

Anaphylaxis is primarily a clinical diagnosis. It is highly likely when any one of the following three criteria is met:
  1. Acute onset of an illness with skin/mucosal involvement AND at least one of: respiratory compromise or reduced BP/end-organ dysfunction
  2. Two or more of the following occurring rapidly after exposure to a likely allergen: skin/mucosal symptoms, respiratory compromise, reduced BP, or persistent GI symptoms
  3. Reduced BP after exposure to a known allergen for that patient
Common triggers: Foods (peanuts, tree nuts, shellfish), medications (antibiotics, NSAIDs, radiocontrast media, chemotherapy, biologics), insect stings (hymenoptera), latex, and exercise. In up to 20% of cases, no trigger is identified (idiopathic).
Serum tryptase peaks at ~1 hour after onset and may remain elevated for up to 4 hours - useful for retrospective confirmation but should not delay treatment.

Immediate Emergency Management (Box 106.7, Rosen's EM)

Step 1 - Simultaneous Emergency Measures

  • Remove the triggering agent if identifiable (e.g., stop IV drug infusion, remove insect stinger)
  • Position: Place patient supine; elevate legs if hypotensive. Sitting the patient upright at onset is associated with worse outcomes
  • Begin cardiac monitoring, pulse oximetry, and BP monitoring
  • Establish large-bore IV access (16-18 gauge preferred)
  • Administer supplemental oxygen
  • Prepare for endotracheal intubation (early intubation is critical if angioedema threatens the airway - delay risks complete obstruction)
  • Begin rapid infusion of isotonic crystalloid (normal saline):
    • Adults: 1000 mL IV in first 5 min (several liters may be required)
    • Pediatrics: 20-30 mL/kg IV increments

Drug Treatment

First-Line: Epinephrine (IMMEDIATE - No Absolute Contraindications)

Epinephrine is the only first-line drug. It must not be delayed, replaced, or preceded by antihistamines or steroids.
Mechanism: α1 - vasoconstriction + reduces mucosal edema; β1 - increased HR and cardiac contractility; β2 - bronchodilation and mast cell stabilization
RouteAdult DosePediatric Dose
IM (preferred) - anterolateral thigh0.3-0.5 mg (0.3-0.5 mL of 1:1000/1 mg/mL solution) q5-10 min0.01 mg/kg (max 0.5 mg) IM q5-10 min
AutoinjectorEpiPen 0.3 mg (adults)EpiPen Jr 0.15 mg (children <30 kg)
IV bolus (cardiovascular collapse)100 mcg over 5-10 min (mix 0.1 mg in 10 mL NS)-
IV infusion (refractory)Start at 1 mcg/min; titrate to max 10 mcg/min (1 mg in 1000 mL NS/D5W = 1 mcg/mL)0.1-1.5 mcg/kg/min; titrate
Key points:
  • IM into the anterolateral thigh achieves higher, faster, and more consistent peak plasma levels than deltoid or SC injection
  • SC injection is no longer recommended - IM is superior
  • IV epinephrine carries risk of dysrhythmia; requires careful cardiac monitoring and dilution
  • Central venous access is preferred for IV infusion to avoid tissue necrosis from extravasation
  • There is no absolute contraindication in anaphylaxis, including in patients with cardiovascular disease - benefits far outweigh risks
  • Most patients need only a single IM dose

Second-Line Agents (After Epinephrine - Never Instead of It)

H1 Antihistamines

Relieve urticaria and pruritus but have no immediate effect on the anaphylactic reaction itself:
DrugAdultPediatric
Diphenhydramine (H1)25-50 mg IV/IM/PO q6h1 mg/kg IV/IM/PO q6h
Cetirizine (H1)10 mg oral or IV5-10 mg oral or IV

H2 Antihistamines

DrugAdultPediatric
Famotidine40 mg IV0.5 mg/kg IV over 5 min
Ranitidine50 mg IV over 5 min0.5 mg/kg IV over 5 min
Cimetidine300 mg IV4-8 mg/kg IV

Corticosteroids

No significant immediate effect and do not reliably prevent biphasic reactions, but are given to attenuate prolonged reactions:
DrugAdultPediatric
Hydrocortisone250-500 mg IV5-10 mg/kg IV (max 500 mg)
Methylprednisolone80-125 mg IV1-2 mg/kg IV (max 125 mg)
Prednisone (oral)40-60 mg PO daily for 3-5 days1-2 mg/kg/day for 3-5 days

For Bronchospasm (In Addition to Epinephrine)

Albuterol (salbutamol):
  • Adults: 2.5-5 mg nebulized (diluted to 3 mL NS), or 4-6 puffs MDI, q20 min as needed
  • Pediatric: 1.25-2.5 mg nebulized q20 min
Ipratropium:
  • Adults: 0.5 mg in 3 mL NS nebulized

For Refractory Anaphylaxis

Refractory to IM Epinephrine + Fluids

Initiate IV epinephrine infusion as above. If dangerous dysrhythmias or tachycardia limit epinephrine use, consider other vasopressors:
VasopressorDose
Dopamine5-20 mcg/kg/min continuous IV infusion
Norepinephrine0.05-0.5 mcg/kg/min
Phenylephrine1-5 mcg/kg/min
Vasopressin0.01-0.4 units/min

Patients on Beta-Blockers

Epinephrine may have blunted effect due to β-receptor blockade, and may cause severe hypertension from unopposed α-stimulation. Use glucagon:
  • Dose: 1-5 mg IV bolus slowly over 5 min, then 5-15 mcg/min IV infusion, titrated to clinical response
  • Monitor for nausea and vomiting (side effects of glucagon)

Airway Management

  • Early intubation is preferred if there is evidence of angioedema-related respiratory distress - any delay risks complete obstruction
  • Prepare for adjunct airway techniques: awake fiberoptic intubation, surgical airway (cricothyrotomy)
  • If laryngeal edema is not rapidly responsive to epinephrine, cricothyroidotomy or tracheotomy may be required
  • Maintain O2 saturation >90%

Positioning

  • Supine with legs elevated (Trendelenburg) is standard
  • If respiratory distress or vomiting, modify to semi-recumbent
  • Never allow the patient to stand or sit suddenly - "empty caval syndrome" (positional cardiovascular collapse) can cause fatal cardiac arrest when moving from supine to upright

Disposition and Observation

Biphasic anaphylaxis (recurrence of symptoms 1-72 hours after initial resolution) occurs in up to 5-23% of cases. Patients should be observed after symptom resolution.
Observation period guidelines:
Clinical ScenarioRecommended Observation
Mild reaction, resolved, otherwise healthyMinimum 1 hour asymptomatic
Typical anaphylaxis4-6 hours
Severe/protracted anaphylaxis6-24 hours or admission
Received IV epinephrine or >1 dose IMProlonged observation or admission
High-risk features (asthma, prior severe reaction, beta-blocker use, elderly, lives alone)Prolonged observation or admit
Indications for hospital admission:
  • Protracted anaphylaxis or refractory hypotension
  • Airway involvement
  • Unknown trigger
  • IV epinephrine required
  • More than one dose of IM epinephrine given
  • Poor social support or lives alone far from medical care

Discharge Planning

Every patient discharged after anaphylaxis must receive:
  1. Epinephrine autoinjector (at least 2 prescribed; carry at all times and store at multiple locations - home, vehicle, work)
  2. Antihistamines: Diphenhydramine 25-50 mg PO q6-8h for 3-5 days
  3. Corticosteroids: Prednisone 40-60 mg PO daily (or 20-30 mg BID) for 3-5 days
  4. Written emergency action plan
  5. Education on: recognizing anaphylaxis, allergen avoidance, proper use of autoinjector (fewer than 1/3 of patients can demonstrate correct use without instruction), wearing a MedicAlert bracelet
  6. Referral to allergist/immunologist for trigger identification and desensitization planning
  7. Patients on beta-blockers should have their antihypertensive switched to a different drug class

Special Situations

Perioperative Anaphylaxis

  • Frequency: ~1 in 2,000-10,000 cases
  • Common triggers: neuromuscular blocking agents, antibiotics, latex, chlorhexidine, induction agents
  • Management is the same; maintain high index of suspicion intraoperatively

Radiocontrast Anaphylaxis - Pre-medication Protocol

For patients with prior contrast reaction requiring re-exposure:
  • Prednisone 50 mg PO at 13, 7, and 1 hour before procedure
  • Diphenhydramine 50 mg PO 1 hour before procedure
  • Consider ephedrine 25 mg PO 1 hour before
  • Consider famotidine 20 mg PO 3 hours before

Non-histaminergic Angioedema (Hereditary Angioedema / ACE-inhibitor angioedema)

  • Does not reliably respond to epinephrine and antihistamines (though these should still be tried initially)
  • Specific agents for hereditary angioedema (HAE):
    • Icatibant (bradykinin B2 receptor antagonist)
    • Ecallantide (plasma kallikrein inhibitor)
    • Human or recombinant C1 esterase inhibitor
    • Fresh frozen plasma (FFP) as an alternative

Summary: Priority Hierarchy

ANAPHYLAXIS SUSPECTED
       ↓
1. EPINEPHRINE IM (anterolateral thigh) - IMMEDIATELY
       ↓
2. Supine position + O2 + IV access + fluids
       ↓
3. Monitor: cardiac, SpO2, BP
       ↓
4. Airway: early intubation if angioedema threatens
       ↓
5. If refractory: IV epinephrine infusion ± vasopressors
   If on β-blocker: add Glucagon
       ↓
6. Second-line: antihistamines + corticosteroids + bronchodilators
       ↓
7. Observe 4-6h minimum; admit if severe
       ↓
8. Discharge: EpiPen + steroids + antihistamines + allergist referral

Sources: ROSEN's Emergency Medicine (9e), p. 2386-2395 | Tintinalli's Emergency Medicine (9e), pp. 108-114 | The Washington Manual of Medical Therapeutics, p. 427 | Goldman-Cecil Medicine (26e), Chapter 233 | Textbook of Family Medicine (9e)
This is a shared conversation. Sign in to Orris to start your own chat.